Session Learning Objectives

Those attending this session will receive information that should allow them to:

• Discuss epidemiological trends and mortality rates;
• Explain the pathophysiology of renal injury in advanced cirrhosis;
• Clarify diagnostic criteria and nomenclature;
• Review current and emerging best practices in management;
• Provide practical advice regarding diagnosis and management of HRS; and
• Discuss the role of Terlipressin as it becomes available in US hospitals